1,813
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease

, , , , , , , & ORCID Icon show all
Article: 2163784 | Received 10 Aug 2022, Accepted 26 Dec 2022, Published online: 07 Jan 2023

Reprints and Permissions

Taylor & Francis does not sell reprints or permissions for this article. Please refer to the 'Licensing' tab on the article menu bar for information on the reuse conditions associated with this license type.